-
1دورية أكاديمية
المؤلفون: Elías, E.E., Almejún, M.B., Colado, A., Cordini, G., Vergara-Rubio, M., Podaza, E., Risnik, D., Cabrejo, M., Fernández-Grecco, H., Bezares, R.F., Custidiano, M.R., Sánchez-Ávalos, J.C., Vicente, Á., Garate, C.M., Borge, M., Giordano, M., Gamberale, R.
-
2دورية أكاديمية
المؤلفون: Almejún, M.B., Borge, M., Colado, A., Elías, E.E., Podaza, E., Risnik, D., De Brasi, C.D., Stanganelli, C., Slavutsky, I., Cabrejo, M., Fernández-Grecco, H., Bezares, R.F., Cranco, S., Burgos, R.Á., Sánchez-Ávalos, J.C., Oppezzo, P., Giordano, M., Gamberale, R.
مصطلحات موضوعية: B lymphocyte receptor, beta 2 microglobulin, beta actin, carboxyfluorescein diacetate succinimidyl ester, CD38 antigen, CD40 ligand, CD49 antigen, CD69 antigen, epigallocatechin gallate, immunoglobulin G, immunoglobulin M, immunoglobulin M antibody, lactate dehydrogenase, messenger RNA, sphingosine kinase 1, unclassified drug, biological marker, phosphotransferase, sphingosine kinase, B lymphocyte, cell activation, cell adhesion, cell death, cell migration, cell proliferation, cell survival, chronic lymphatic leukemia, clinical article, clinical outcome, controlled study
-
3دورية أكاديمية
المؤلفون: Risnik, D., Podaza, E., Almejún, M.B., Colado, A., Elías, E.E., Bezares, R.F., Fernández-Grecco, H., Cranco, S., Sánchez-Ávalos, J.C., Borge, M., Gamberale, R., Giordano, M.
-
4دورية أكاديمية
المؤلفون: Colado, A., Genoula, M., Cougoule, C., Marín Franco, J.L., Almejún, M.B., Risnik, D., Kviatcovsky, D., Podaza, E., Elías, E.E., Fuentes, F., Maridonneau-Parini, I., Bezares, F.R., Fernandez Grecco, H., Cabrejo, M., Jancic, C., Sasiain, M.C., Giordano, M., Gamberale, R., Balboa, L., Borge, M.
مصطلحات موضوعية: colony stimulating factor 1, ibrutinib, interleukin 10, interleukin 4, cancer patient, chronic lymphatic leukemia, disease association, drug efficacy, gamma delta T lymphocyte, glucose intake, human, immune response, incidence, infection risk, Letter, macrophage, Mycobacterium tuberculosis, natural killer cell, nonhuman, phagocytosis, protein phosphorylation, treatment response, world health organization
-
5دورية أكاديمية
المؤلفون: Colado, A., Almejún, M.B., Podaza, E., Risnik, D., Stanganelli, C., Elías, E.E., Dos Santos, P., Slavutsky, I., Fernández Grecco, H., Cabrejo, M., Bezares, R.F., Giordano, M., Gamberale, R., Borge, M.
مصطلحات موضوعية: BCR-associated kinase inhibitors, Chronic lymphocytic leukemia, GS-9973, R406, Syk inhibitors, CD40 ligand, chemokine receptor CCR7, chemokine receptor CXCR4, entospletinib, fostamatinib, gamma interferon, interleukin 10, interleukin 4, protein kinase Syk, protein kinase ZAP 70, rituximab, 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine, indazole derivative, lymphocyte antigen receptor, N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine, oxazine derivative, pyrazine derivative, pyridine derivative, antineoplastic activity, Article, cancer patient, CD4+ T lymphocyte, cell migration, chronic lymphatic leukemia, controlled study